By Gwenaëlle Douaud, et al. With comment from Dr. Bob Rufsvold The research from the UK is a worrisome tip-of-the-iceberg indicator, one that goes beyond our current understanding of “Long COVID” symptoms that many people are experiencing.Bob Rufsvold MD Abstract...
Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis
By Mahesh B. Shenai ~This article is a preprint and has not been peer-reviewed September 21, 2021 Abstract BACKGROUND We present a systematic review and pooled analysis of clinical studies to date, that (1) specifically compare the protection of natural immunity...
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
By Venice Servellita, et al. PREPrint ~ August 25, 2021 with Commentary from TrialSiteNews Below Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed...
Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial
By Gilmar Reis, et al. PREPRINT August 23, 2021 ABSTRACT Background Recent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER randomized platform clinical trial for acutely symptomatic patients with COVID-19, we assessed...
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
By Sivan Gazit, et al. Abstract Background Reports of waning vaccine-induced immunity against COVID-19 have begun to surface. With that, the comparable long-term protection conferred by previous infection with SARS-CoV-2 remains unclear. Methods We conducted...
Brain imaging before and after COVID-19 in UK Biobank
June 15, 2021 ~ MedRxiv ~ Gwenaëlle Douaud et al. Brain imaging before and after COVID-19 in UK Biobank Abstract There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain...
Necessity of COVID-19 vaccination in previously infected individuals
June 5, 2021 ~ MedRxiv ~ by Nabin K. Shrestha et al. Necessity of COVID-19 vaccination in previously infected individuals ABSTRACT Background The purpose of this study was to evaluate the necessity of COVID-19 vaccination in persons previously infected with...
Toxoplasmosis: An important risk factor for acquiring SARS-CoV-2 infection and a severe course of Covid-19 disease
By Jaroslav Flegr Summary Background Latent toxoplasmosis, i.e. a lifelong infection with the protozoan parasite Toxoplasma gondii, affects about a third of human population worldwide. In the past ten years, numerous studies had shown that infected...
SARS-CoV-2 antibodies detected in human breast milk post-vaccination
https://www.covidstrategies.org/sars-cov-2-antibodies-detected-in-human-breast-milk-post-vaccination/https://www.medrxiv.org/content/10.1101/2021.02.23.21252328v1 Originally published by: MedRxiv Author: Jill Baird, et al. Date: 3/2/2021 Categories: Integrative Therapies,Prevention,Vaccines
Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis
https://www.covidstrategies.org/outcomes-of-ivermectin-in-the-treatment-of-covid-19-a-systematic-review-and-meta-analysis/https://www.medrxiv.org/content/10.1101/2021.01.26.21250420v1 Originally published by: MedRxiv Author: Castaneda-Sabogal et al. Date: 1/26/2021 Categories: Integrative Therapies,Treatment,Ivermectin
THE THERAPEUTIC POTENTIAL OF IVERMECTIN FOR COVID-19: A SYSTEMATIC REVIEW OF MECHANISMS AND EVIDENCE
https://www.covidstrategies.org/the-therapeutic-potential-of-ivermectin-for-covid-19-a-systematic-review-of-mechanisms-and-evidence/https://www.medrxiv.org/content/10.1101/2020.11.30.20236570v1.full Originally published by: MedRxIV Author: Kalfas, et al. Date: 12/4/2020 Categories: Integrative Therapies,Treatment,Ivermectin
The use of compassionate Ivermectin in the management of symptomatic outpatients and hospitalized patients with clinical diagnosis of COVID-19 at the Medical Center Bournigal and the Medical Center Punta Cana, Rescue Group, Dominican Republic, from may 1 to august 10, 2020
https://www.covidstrategies.org/the-use-of-compassionate-ivermectin-in-the-management-of-symptomatic-outpatients-and-hospitalized-patients-with-clinical-diagnosis-of-covid-19-at-the-medical-center-bournigal-and-the-medical-center-pu/https://www.medrxiv.org/content/10.1101/2020.10.29.20222505v1 Originally published by: MedRxiv Author: José Morgenstern, et al. Date: 11/1/2020 Categories: Prevention,Integrative Therapies,Treatment,Ivermectin